BRUTON'S TYROSINE KINASE INHIBITION TO SUPPRESS MAST CELL ACTIVATION IN ATHEROSCLEROSIS

被引：0
|
作者：
Hemme, E. [1 ]
Delfos, L. [1 ]
Depuydt, M. A. C. [1 ]
Kleijn, M. N. A. Bernabe [1 ]
Schaftenaar, F. H. [1 ]
Foks, A. C. [1 ]
Kuiper, J. [1 ]
Bot, I. [1 ]
机构：
[1] Leiden Univ, Biotherapeut, LACDR, Leiden, Netherlands
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP050
引用
收藏
页码：E100 / E100
页数：1
相关论文
共 50 条
  • [11] Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier
    Payne, Aimee S.
    Vieira, Silvio Manfredo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : 1667 - 1670
  • [12] Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells
    Lee, Seung-Cheol
    Shestov, Alexander A.
    Guo, Lili
    Zhang, Qian
    Roman, Jeffrey C.
    Liu, Xiaobin
    Wang, Hong Y.
    Pickup, Stephen
    Nath, Kavindra
    Lu, Pin
    Hofbauer, Samuel
    Mesaros, Clementina
    Wang, Y. Lynn
    Nelson, David S.
    Schuster, Stephen J.
    Blair, Ian A.
    Glickson, Jerry D.
    Wasik, Mariusz A.
    MOLECULAR CANCER RESEARCH, 2019, 17 (06) : 1365 - 1377
  • [13] Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors
    Schwarz, Emily
    Benner, Brooke
    Wesolowski, Robert
    Quiroga, Dionisia
    Good, Logan
    Sun, Steven H.
    Savardekar, Himanshu
    Li, Jianying
    Jung, Kyeong Joo
    Duggan, Megan C.
    Lapurga, Gabriella
    Shaffer, Jami
    Scarberry, Luke
    Konda, Bhavana
    Verschraegen, Claire
    Kendra, Kari
    Shah, Manisha
    Rupert, Robert
    Monk, Paul
    Shah, Hiral A.
    Noonan, Anne M.
    Bixel, Kristin
    Hays, John
    Wei, Lai
    Pan, Xueliang
    Behbehani, Gregory
    Hu, Yang
    Elemento, Olivier
    Chung, Dongjun
    Xin, Gang
    Blaser, Bradley W.
    Carson III, William E.
    JCI INSIGHT, 2024, 9 (21)
  • [14] Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
    Arneson, Laura C.
    Carroll, Kristen J.
    Ruderman, Eric M.
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 333 - 342
  • [15] Bruton's tyrosine kinase inhibition for the treatment of allergic disorders
    Lin, Erica V.
    Suresh, Ragha V.
    Dispenza, Melanie C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (01) : 33 - 42
  • [16] Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells
    Zorn, Carolin N.
    Keck, Simone
    Hendriks, Rudi W.
    Leitges, Michael
    Freudenberg, Marina A.
    Huber, Michael
    CELLULAR SIGNALLING, 2009, 21 (01) : 79 - 86
  • [17] Bruton Tyrosine Kinase Inhibition in Dermatology and Allergology
    Wedi, B.
    HAUTARZT, 2018, 69 (06): : 519 - 522
  • [18] The tyrosine kinase network regulating mast cell activation
    Gilfillan, Alasdair M.
    Rivera, Juan
    IMMUNOLOGICAL REVIEWS, 2009, 228 : 149 - 169
  • [19] Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
    Chen, Siyue
    Liu, Yuming
    Zhang, Yutian
    Guo, Xu
    Bai, Tinghui
    He, Kai
    Zhu, Yanfang
    Lei, Yi
    Du, Mei
    Wang, Xiaohong
    Liu, Qiang
    Yan, Hua
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [20] The emerging role of Bruton's tyrosine kinase inhibition in urticaria management
    Lauletta, Giuseppe
    Potestio, Luca
    Patruno, Cataldo
    Cantelli, Mariateresa
    Napolitano, Maddalena
    EXPERT OPINION ON DRUG SAFETY, 2025,
12345